- Home
- LNSR vs CCEL Comparison
LNSR vs CCEL Comparison
Compare LNSR & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- CCEL
- Stock Information
- Founded
- LNSR 2004
- CCEL 1989
- Country
- LNSR United States
- CCEL United States
- Employees
- LNSR N/A
- CCEL N/A
- Industry
- LNSR Medical Electronics
- CCEL Managed Health Care
- Sector
- LNSR Health Care
- CCEL Health Care
- Exchange
- LNSR Nasdaq
- CCEL Nasdaq
- Market Cap
- LNSR 63.4M
- CCEL 51.9M
- IPO Year
- LNSR N/A
- CCEL 1997
- Fundamental
- Price
- LNSR $14.09
- CCEL $6.47
- Analyst Decision
- LNSR Hold
- CCEL Strong Buy
- Analyst Count
- LNSR 1
- CCEL 1
- Target Price
- LNSR $15.00
- CCEL $8.50
- AVG Volume (30 Days)
- LNSR 248.3K
- CCEL 16.7K
- Earning Date
- LNSR 05-08-2025
- CCEL 04-14-2025
- Dividend Yield
- LNSR N/A
- CCEL 3.91%
- EPS Growth
- LNSR N/A
- CCEL N/A
- EPS
- LNSR N/A
- CCEL 0.05
- Revenue
- LNSR $53,494,000.00
- CCEL $31,986,106.00
- Revenue This Year
- LNSR $29.95
- CCEL $2.21
- Revenue Next Year
- LNSR $29.35
- CCEL $0.98
- P/E Ratio
- LNSR N/A
- CCEL $129.41
- Revenue Growth
- LNSR 26.87
- CCEL 2.05
- 52 Week Low
- LNSR $2.67
- CCEL $5.75
- 52 Week High
- LNSR $17.31
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- LNSR 53.30
- CCEL 41.03
- Support Level
- LNSR $14.06
- CCEL $6.13
- Resistance Level
- LNSR $14.25
- CCEL $6.56
- Average True Range (ATR)
- LNSR 0.73
- CCEL 0.41
- MACD
- LNSR -0.29
- CCEL 0.03
- Stochastic Oscillator
- LNSR 2.46
- CCEL 44.64
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.